STOCK TITAN

Baird Medical Investment (BDMD) holders detail 19.1% ownership stake

(Moderate)
(Neutral)
Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

Baird Medical Investment Holdings Ltd’s ordinary shares are the subject of a Schedule 13D filed by ExcelFin SPAC LLC, Grand Fortune Capital (HK) Company Limited, and Grand Fortune Capital LLC following a business combination involving the issuer.

Based on 36,725,899 ordinary shares outstanding as of January 15, 2026, ExcelFin beneficially owns 4,249,031 shares (11.6%). Grand Fortune Capital LLC beneficially owns 290,000 shares on an as-converted basis from Series A Preferred Shares (0.8%). Grand Fortune Capital (HK) Company Limited is deemed to beneficially own 7,004,016 shares (19.1%), including ExcelFin’s holdings and the convertible preferred position of Grand Fortune Capital LLC. The securities were obtained through the business combination, conversion of working capital loans at $10.20 per share, and a $2.9 million preferred share subscription. The reporting persons state they hold the position for investment purposes and may acquire or dispose of BDMD securities or discuss strategy, governance, and potential transactions with the company.

Positive

  • None.

Negative

  • None.

Filing Explained

GFCHK’s three-manager board must approve voting or disposal decisions involving the reported holdings; GFC’s preferred shares are convertible at the holder’s election.

The filing reports the holdings as beneficially owned, with GFCHK controlling GFC and decisions involving GFC’s or ExcelFin’s securities requiring at least a majority vote of GFCHK’s three-manager board.

GFC’s 290,000 Series A Preferred Shares are held under the subscription agreement and are convertible at any time at the holder’s election into ordinary shares, so the reported preferred position is stated on an as-converted basis.

For the past 60 days, the reporting persons state that none effected transactions in the issuer’s securities.

Shares outstanding 36,725,899 ordinary shares Ordinary shares outstanding as of January 15, 2026
ExcelFin ownership 4,249,031 ordinary shares (11.6%) Beneficially owned by ExcelFin SPAC LLC
Grand Fortune Capital (HK) ownership 7,004,016 ordinary shares (19.1%) Deemed beneficially owned by Grand Fortune Capital (HK) Company Limited
Grand Fortune Capital LLC ownership 290,000 ordinary shares (0.8%) Beneficially owned on an as-converted basis from Series A Preferred Shares
Loan conversion shares 278,406 ordinary shares Converted from working capital loans at $10.20 per share
ExcelFin business combination shares 2,620,625 ordinary shares Acquired by ExcelFin in the business combination, including founder or sponsor shares
GFCHK business combination shares 2,464,985 ordinary shares Acquired by Grand Fortune Capital (HK), including 564,437 earnout shares
Preferred share subscription $2.9 million Consideration paid for 290,000 Series A Preferred Shares convertible into ordinary shares
beneficially owns financial
"Beneficially owns 4,249,031 Ordinary Shares, representing approximately 11.6%"
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
Series A Preferred Shares financial
"290,000 shares of Series A Preferred Shares of the Issuer"
Series A preferred shares are an early-stage class of ownership sold to investors that gives them special protections and payment priority over regular common stock. Think of them as a safer seat on a bus: if the company earns money or is sold, holders get paid before ordinary shareholders, and they often can convert to common shares later to share upside; that mix of safety and growth potential helps investors manage risk and reward.
earnout financial
"GFCHK acquired 2,464,985 Ordinary Shares in connection with the Business Combination, which includes 564,437 shares subject to an earnout"
An earnout is a financial agreement in which part of the purchase price for a business is paid later, based on the company's future performance. It acts like a bonus system, where sellers earn extra money if the business hits certain goals, aligning their interests with the buyer’s success. Investors pay attention to earnouts because they influence the total deal value and can affect the company's future financial health.
Rule 13d-3(d)(1) regulatory
"deemed to be beneficially owned under Rule 13d-3(d)(1)"
joint filing agreement regulatory
"The Reporting Persons are party to a joint filing agreement pursuant to Rule 13d-1(k)"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Baird Medical (BDMD) does Grand Fortune Capital (HK) beneficially own?

Grand Fortune Capital (HK) Company Limited is deemed to beneficially own 7,004,016 BDMD ordinary shares, representing 19.1% of the outstanding class. This figure aggregates shares it holds directly, ExcelFin’s holdings, and 290,000 shares issuable upon conversion of Series A Preferred Shares held by an affiliate.

How many Baird Medical (BDMD) shares does ExcelFin SPAC LLC control?

ExcelFin SPAC LLC beneficially owns 4,249,031 BDMD ordinary shares, equal to approximately 11.6% of shares outstanding. Its stake includes 2,620,625 shares from the business combination and 278,406 shares from converting working capital loans at $10.20 per share.

What is Grand Fortune Capital LLC’s investment structure in Baird Medical (BDMD)?

Grand Fortune Capital LLC holds 290,000 Series A Preferred Shares acquired for $2.9 million. These preferred shares are convertible at any time, at the holder’s election, into 290,000 BDMD ordinary shares, giving it a 0.8% beneficial ownership stake on an as-converted basis.

How were the BDMD shares acquired by the reporting persons?

ExcelFin and Grand Fortune Capital (HK) acquired BDMD ordinary shares through a business combination involving ExcelFin Acquisition Corp., including founder/sponsor shares and an earnout of 564,437 shares. Additional shares came from working capital loan conversions at $10.20 per share and a $2.9 million preferred subscription.

What is the stated purpose of the reporting persons’ investment in BDMD?

The reporting persons state they acquired BDMD securities for investment purposes. They indicate they may buy more or sell shares, and may engage with management on business strategy, capitalization, governance, and potential strategic transactions, including financings, asset sales, mergers, or other combinations.

How many Baird Medical (BDMD) ordinary shares are outstanding and as of what date?

There are 36,725,899 BDMD ordinary shares outstanding, based on issuer information as of January 15, 2026. The ownership percentages reported by ExcelFin, Grand Fortune Capital (HK), and Grand Fortune Capital LLC are each calculated relative to this outstanding share count.





G0705H103

(CUSIP Number)
Grand Fortune Capital Co., LTD
Flat/Rm 2, 5/F, Greenfield Tower, Concordia Plaza, No. 1 Science Museum Rd
Tsim Sha Tsui, Kln, K3, 000000
267-254-7178

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
10/01/2024

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


ExcelFin SPAC LLC
Signature:/s/ Goh Lin Piao
Name/Title:Goh Lin Piao, its Director
Date:07/28/2026
Grand Fortune Capital (HK) Co Ltd
Signature:/s/ Goh Lin Piao
Name/Title:Goh Lin Piao, its Director
Date:07/28/2026
Grand Fortune Capital, LLC
Signature:/s/ Goh Lin Piao
Name/Title:Goh Lin Piao, its Director
Date:07/28/2026
Comments accompanying signature:
ExcelFin SPAC LLC, By: Grand Fortune Capital, LLC, its Managing Member, By: Grand Fortune Capital (HK) Company Ltd., its Managing Member. Grand Fortune Capital, LLC, By: Grand Fortune Capital (HK) Company Ltd.,its Managing Member